Track Rapid Micro Biosystems Inc. Class A Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Rapid Micro Biosystems Inc. Class A Common Stock RPID · Stock Open Rapid Micro Biosystems Inc. Class A Common Stock in new tab

0.6510 USD
EPS
-1.11
P/B
1.83
ROE
-141.65
Beta
1.48
Target Price
6.00 USD
Rapid Micro Biosystems Inc. Class A Common Stock logo

Rapid Micro Biosystems Inc. Class A Common Stock

🧾 Earnings Recap – Q2 2026

Shares declined 16.8% following earnings as investors reacted negatively to cautious outlook signals and potential margin compression, despite solid revenue growth and record gross margins.

  • Q2 revenue grew 11% year-over-year to $8.1 million, driven by 10% product revenue growth and 14% recurring revenue expansion.
  • Company placed 4 Growth Direct Systems and completed 9 system validations; validation guidance was increased to at least 27 systems for the full year.
  • Delivered a record 15% gross margin in the quarter, with confidence in reaching mid-to-high 20% margins by Q4.
  • Management emphasized ongoing customer engagement and commercial events to drive future adoption but signaled caution for the second half.
  • Despite operational progress, investor concerns likely stem from cautious outlook elements and possible deceleration or margin risks implicit in commentary.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 26, 2027
EPS-1.11
Book Value0.36
Price to Book1.83
Debt/Equity132.29
% Insiders10.106%
Growth
Revenue Growth0.11%
Estimates
Forward P/E-0.88
Forward EPS-0.74
Target Mean Price6.00

DCF valuation

Model fair value for Rapid Micro Biosystems Inc. Class A Common Stock (RPID)
Result
Sign in to run the valuation for RPID.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
3 analysts · consensus Strong buy · mean target 6.00 USD (low 3.00, high 8.00) · as of 15 Nov 2026
Low 3.00
Mean 6.00
High 8.00
Price 0.6510
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Rapid Micro Biosystems Inc. Class A Common Stock Logo Rapid Micro Biosystems Inc. Class A Common Stock Analysis (RPID)

United States Health Care Official Website Stock

Is Rapid Micro Biosystems Inc. Class A Common Stock a good investment? Rapid Micro Biosystems Inc. Class A Common Stock (RPID) is currently trading at 0.6510 USD. Market analysts have a consensus price target of 6.00 USD. This suggests a potential upside from current levels.

Earnings Schedule: Rapid Micro Biosystems Inc. Class A Common Stock is expected to release its next earnings report on Feb. 26, 2027. The market consensus estimate for Forward EPS is -0.74.

Investor FAQ

Does Rapid Micro Biosystems Inc. Class A Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Rapid Micro Biosystems Inc. Class A Common Stock?

Rapid Micro Biosystems Inc. Class A Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 26, 2027. The company currently has a trailing EPS of -1.11.

Company Profile

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Exchange Ticker
NMS (United States) RPID
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion